CreamMRP Under Process
Official PMBI MRP is being updated for catalog code 1635.
Locate Jan Aushadhi KendraClinical Overview
Framycetin Sulphate (1% w/w cream) is a broad-spectrum aminoglycoside bactericidal antibiotic. It binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis. Active against Staphylococcus aureus, Pseudomonas aeruginosa, and coliform bacteria. Indicated for treatment of superficial skin infections, burns, scalds, ulcers, cuts, abrasions, and impetigo.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Apply a thin layer to clean affected area 1 to 3 times daily. May be covered with a sterile gauze dressing. Wash hands after use.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Local burning, erythema, contact dermatitis. Rare/Severe: Ototoxicity and nephrotoxicity if applied over extensive open wounds or large burned surfaces.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Do not apply to large raw, denuded surfaces or deep open ulcers due to systemic aminoglycoside absorption risk. Avoid contact with eyes.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Beclomethasone Dipropionate 0.025%, Clotrimazole 1% and Gentamicin Sulphate 0.1% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Beclomethasone 0.025% and Neomycin 0.5% Cream
Beclomethasone 0.025% and Neomycin 0.5% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Fusidic Acid Cream 2%
Fusidic Acid (2% w/w cream) is a steroid-like antibacterial agent that inhibits bacterial protein synthesis by interfering with elongation factor G (EF-G) on the ribosome. Highly active against Staphylococcus aureus, including methicillin-resistant strains (MRSA) and Corynebacterium species. Penetrates intact skin effectively. Indicated for impetigo, folliculitis, erythrasma, furunculosis, and infected wounds.
Povidone Iodine Ointment 5% w/w
Povidone Iodine Ointment 5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.